Each ml contains:
Marbofloxacin 100.0 mg
Therapeutic treatment of respiratory infections caused by sensitive strains of Pasteurella multocida, Mannheimia haemolytica and Histophilus somni. Therapeutic treatment of acute mastitis caused by E. coli strains sensitive to marbofloxacin during the lactation period.
Treatment of Metritis Mastitis Agalactia Syndrome caused by bacterial strains sensitive to marbofloxacin.
Do not use in animals with known hypersensitivity to marbofloxacin or other quinolones.
Do not use in case of confirmed or suspected resistance to fluoroquinolones (cross resistance).
Special precautions for use in animals
Use of the product should be based on susceptibility testing and has to take into account official and local antimicrobial policies. It is prudent to reserve the fluoroquinolones for the treatment of clinical conditions that have responded poorly, or are expected to respond poorly, to other classes of antibiotics. Use of the product deviating from the instructions given in the SPC may increase the prevalence of bacteria resistant to the fluoroquinolones and may decrease the effectiveness of treatment with other quinolones due to the potential for cross resistance. As the vial cannot be broached more than 45 times, the user should choose the most appropriate vial size according to the target species to treat.
Special precautions to be taken by the person administering the veterinary medicinal product to animals
People with known hypersensitivity to (fluoro)quinolones should avoid any contact with the product. If the product comes into contact with the skin or eyes, rinse with copious amounts of water. Take care to avoid accidental self-injection since it can induce a slight irritation. In case of accidental self-injection, seek medical advice immediately and show the package leaflet to the physician. Wash hands after use.
- Intramuscular use:
Respiratory infections: The recommended dosage is 8 mg/kg bodyweight i.e. 2 ml/25 kg bodyweight in a single injection. If the volume to be injected is more than 20 ml, it should be divided between two or more injection sites.
- Subcutaneous use:
Acute mastitis: The recommended dosage is 2 mg/kg i.e. 1 ml/50 kg bodyweight in a single daily injection, for 3 days. The first injection may also be given by the intravenous route too.
- Intramuscular use:
Intramuscular use: The recommended dosage is 2 mg/kg i.e.1 ml/50kg bodyweight in a single daily injection by intramuscular route, for 3 days.
Intramuscular: Meat and offal: 3 days - Milk : 72 hours
Subcutaneous: Meat and offal: 6 days - Milk: 36 hours
Intramuscular: Meat and offal: 4 days
Keep the container in the outer carton in order to protect from light.
Cardboard box containing one 50 ml vial
Cardboard box containing one 100 ml vial
Cardboard box containing one 250 ml vial
Cardboard box containing one 500 ml vial
From one country to another, product lines are adapted to local demand and regulatory requirements. For further information, please take a look at the CEVA Santé Animale site for your country. Warning: the information provided on the products depends on national registrations. Access to technical information is restricted to authorised persons.